Skezan, I assume that the analyses will be sim
Post# of 148165
(Total Views: 466)
Posted On: 03/04/2021 6:46:41 PM
Skezan,
I assume that the analyses will be similar, but it would make sense that Cytodyn knows the information independently and is not completely dependent on the FDA.
Ultimately I expect the FDAs results will have primacy, as will the FDAs plan and timeline.
Cytodyn can ultimately sell leronlimab anywhere in the world that it is approved, but bypassing the FDA would be very shortsighted.
I assume that the analyses will be similar, but it would make sense that Cytodyn knows the information independently and is not completely dependent on the FDA.
Ultimately I expect the FDAs results will have primacy, as will the FDAs plan and timeline.
Cytodyn can ultimately sell leronlimab anywhere in the world that it is approved, but bypassing the FDA would be very shortsighted.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼